Reassessing the Human Immunodeficiency Virus Type 1 Life Cycle through Age-Structured Modeling: Life Span of Infected Cells, Viral Generation Time, and Basic Reproductive Number, R0

ABSTRACT The rapid decay of the viral load after drug treatment in patients infected with human immunodeficiency virus type 1 (HIV-1) has been shown to result from the rapid loss of infected cells due to their high turnover, with a generation time of around 1 to 2 days. Traditionally, viral decay dynamics after drug treatment is investigated using models of differential equations in which both the death rate of infected cells and the viral production rate are assumed to be constant. Here, we describe age-structured models of the viral decay dynamics in which viral production rates and death rates depend on the age of the infected cells. In order to investigate the effects of age-dependent rates, we compared these models with earlier descriptions of the viral load decay and fitted them to previously published data. We have found no supporting evidence that infected-cell death rates increase, but cannot reject the possibility that viral production rates increase, with the age of the cells. In particular, we demonstrate that an exponential increase in viral production with infected-cell age is perfectly consistent with the data. Since an exponential increase in virus production can compensate for the exponential loss of infected cells, the death rates of HIV-1-infected cells may be higher than previously anticipated. We discuss the implications of these findings for the life span of infected cells, the viral generation time, and the basic reproductive number, R 0.

[1]  Sebastian Bonhoeffer,et al.  Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis , 1999, The Lancet.

[2]  Patrick W Nelson,et al.  Mathematical analysis of delay differential equation models of HIV-1 infection. , 2002, Mathematical biosciences.

[3]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[4]  Benjamin Gompertz,et al.  On the Nature of the Function Expressive of the Law of Human Mortality , 1815 .

[5]  Rustom Antia,et al.  Mathematical models of cytotoxic T‐lymphocyte killing , 2007, Immunology and cell biology.

[6]  Alan S Perelson,et al.  Estimates of Intracellular Delay and Average Drug Efficacy from Viral Load Data of HIV-Infected Individuals under Antiretroviral Therapy , 2004, Antiviral therapy.

[7]  A. Perelson Modelling viral and immune system dynamics , 2002, Nature Reviews Immunology.

[8]  Douglas D. Richman,et al.  Viral Dynamics of Acute HIV-1 Infection , 1999, The Journal of experimental medicine.

[9]  M A Nowak,et al.  Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Daniel Coombs,et al.  An age-structured model of hiv infection that allows for variations in the production rate of viral particles and the death rate of productively infected cells. , 2004, Mathematical biosciences and engineering : MBE.

[11]  A. Haase,et al.  Determination of simian immunodeficiency virus production by infected activated and resting cells , 2007, AIDS.

[12]  J. Yin,et al.  Quantitative intracellular kinetics of HIV type 1. , 1999, AIDS research and human retroviruses.

[13]  R J D B,et al.  Target Cell Limited and Immune Control Models of HIV Infection : A Comparison , 1998 .

[14]  A. Perelson,et al.  Optimizing within-host viral fitness: infected cell lifespan and virion production rate. , 2004, Journal of theoretical biology.

[15]  Beda Joos,et al.  HIV replication elicits little cytopathic effects in vivo: Analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell death , 2006, Journal of medical virology.

[16]  A. Haase,et al.  Visna DNA synthesis and the tempo of infection in vitro. , 1982, Virology.

[17]  P. Hodgkin,et al.  Modelling cell lifespan and proliferation: is likelihood to die or to divide independent of age? , 2005, Journal of The Royal Society Interface.

[18]  Alan S. Perelson,et al.  Mathematical Analysis of Age-Structured HIV-1 Dynamics with Combination Antiretroviral Therapy , 2007, SIAM J. Appl. Math..

[19]  D. Kirschner,et al.  A model for treatment strategy in the chemotherapy of AIDS. , 1996, Bulletin of mathematical biology.

[20]  L M Wahl,et al.  Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection , 1997, Journal of virology.

[21]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[22]  M. Lipsitch,et al.  How generation intervals shape the relationship between growth rates and reproductive numbers , 2007, Proceedings of the Royal Society B: Biological Sciences.

[23]  Benjamin Gompertz,et al.  XXIV. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. In a letter to Francis Baily, Esq. F. R. S. &c , 1825, Philosophical Transactions of the Royal Society of London.

[24]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.

[25]  A. L. Lloyd,et al.  The dependence of viral parameter estimates on the assumed viral life cycle: limitations of studies of viral load data , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[26]  D. Ho,et al.  The HIV-1 Vaccine Race , 2002, Cell.

[27]  Simon Wain-Hobson Virus Dynamics: Mathematical Principles of Immunology and Virology , 2001, Nature Medicine.